PROCEPT BioRobotics Corp (PRCT)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, PROCEPT BioRobotics Corp reported revenue of $308.05M, up 37.2% from the prior year. The company ran a net loss, with a net margin of -31.0% and a gross margin of 63.7%. It held $508.08M in total assets against $142.21M in total liabilities.
Key ratios (FY2025)
63.7%
Gross margin
-33.7%
Operating margin
-31.0%
Net margin
-26.1%
Return on equity
+37.2%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $308.05M | $224.50M | $136.19M | $75.01M | $34.47M | $7.72M | — |
| Cost of Revenue | $111.83M | $87.40M | $65.14M | $37.93M | $18.61M | $8.97M | — |
| Gross Profit | $196.23M | $137.10M | $71.05M | $37.09M | $15.87M | -$1.25M | — |
| Operating Income | -$103.86M | -$96.61M | -$109.17M | -$80.72M | -$54.16M | -$47.80M | — |
| Net Income | -$95.57M | -$91.41M | -$105.90M | -$87.15M | -$59.85M | -$53.02M | — |
| EPS (Diluted) | $-1.72 | $-1.75 | $-2.24 | $-1.96 | $-3.63 | $-14.47 | — |
| Total Assets | $508.08M | $534.02M | $404.72M | $309.33M | $337.02M | $125.97M | — |
| Total Liabilities | $142.21M | $131.80M | $123.97M | $112.26M | $69.93M | $65.01M | — |
| Shareholders' Equity | $365.87M | $402.22M | $280.75M | $197.07M | $267.09M | -$182.89M | -$143.84M |
| Cash & Equivalents | $286.50M | $333.73M | $257.22M | $221.86M | $304.32M | $100.13M | — |
| Operating Cash Flow | -$48.98M | -$99.21M | -$108.00M | -$80.38M | -$57.33M | -$48.34M | — |
| Capital Expenditures | $9.36M | $4.41M | $25.21M | $2.65M | $592.0K | $233.0K | — |
| Shares Outstanding | 55.54M | 52.12M | 47.26M | 44.40M | 16.48M | 3.66M | — |